Sign in

CIK 0001861107

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Ceribell, Inc.

Sign in to watch
Ticker
CBLL
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471785452
Phone
+1 800-436-0826
Business address
360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,554,752
in 12 filings, $3.3M under 10b5-1 plans

Net −$3,554,752. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-15 Blumberg Scott Chief Financial Officer Exercise or conversion 10b5-1 +846 $9.41 $8K 147,446
2026-09-15 Blumberg Scott Chief Financial Officer Sale 10b5-1 −846 $25.00 $21K 146,600
2026-09-15 Blumberg Scott Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −846 51,802
2026-09-02 Blumberg Scott Chief Financial Officer Exercise or conversion 10b5-1 +652 $9.41 $6K 147,252
2026-09-02 Blumberg Scott Chief Financial Officer Sale 10b5-1 −652 $25.00 $16K 146,600
2026-09-02 Blumberg Scott Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −652 52,648
2026-08-21 Blumberg Scott Chief Financial Officer Sale −1,521 $24.02 $37K 146,600
2026-08-19 Blumberg Scott Chief Financial Officer Exercise or conversion 10b5-1 +6,179 $4.70 $29K 154,300
2026-08-19 Blumberg Scott Chief Financial Officer Exercise or conversion 10b5-1 +27,333 $9.41 $257K 181,633
2026-08-19 Blumberg Scott Chief Financial Officer Sale 10b5-1 −33,512 $25.03 $839K 148,121
2026-08-19 Blumberg Scott Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −6,179 37,224
2026-08-19 Blumberg Scott Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −27,333 53,300
2026-08-18 Blumberg Scott Chief Financial Officer Exercise or conversion 10b5-1 +690 $4.70 $3K 148,811
2026-08-18 Blumberg Scott Chief Financial Officer Exercise or conversion 10b5-1 +300 $9.41 $3K 149,111
2026-08-18 Blumberg Scott Chief Financial Officer Sale 10b5-1 −990 $25.00 $25K 148,121
2026-08-18 Blumberg Scott Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −690 43,403
2026-08-18 Blumberg Scott Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −300 80,633
2026-05-21 Blumberg Scott Chief Financial Officer Sale −1,387 $18.00 $25K 147,683
2026-04-01 Blumberg Scott Chief Financial Officer Grant or award +30,736 149,070
2026-04-01 Blumberg Scott Chief Financial Officer Grant or award · Stock Option (Right to Buy) +51,227 51,227

Page 1 of 2 · 39 trades